河田健司

研究者氏名	河田健司

URL
所属	藤田医科大学
部署	医学部医学科臨床腫瘍科
職名	教授
学位	医学博士
J-Global ID	201501011257698120

MISC

<123 >

The Feasibility Study of Docetaxel in Patients with Anaplastic Thyroid Cancer

Kenji Kawada Koichi Kitagawa Sachi Kamei Megumi Nada Ayako Mitsuma Masataka Sawaki Toyone Kikumori Yasushi Fujimoto Hiroshi Arima Tsuneo Imai Yuichi Ando

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 40(6) 596-599 2010年6月

There is no established chemotherapy for anaplastic thyroid cancer. We conducted a prospective feasibility study at a single center to explore the antitumor activity of docetaxel against anaplastic thyroid cancer. Docetaxel was administered intrav...

抗がん剤の代表的なプロトコール, 大腸癌 FOLFOX,

河田健司

臨床研修プラクティス 5 106-108 2008年

Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumors

Kenji Kawada Koji Murakami Takashi Sato Yoshiki Kojima Hiromichi Ebi Hirofumi Mukai Makoto Tahara Kaoru Shimokata Hironobu Minami

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 37(1) 44-48 2007年1月

Background: To evaluate the role of FDG-PET in assessing anti-tumor efficacy of molecular targeted drugs, we prospectively performed FDG-PET and CT for response evaluation in patients treated with lapatinib, a dual inhibitor of ErbB1 and ErbB2 tyr...

抗がん剤の治験とファーマコジェノミックス

河田健司南博信

癌治療と宿主 16 347-350 2004年

抗がん剤の臨床薬理とpharmacogenomics

河田健司南博信

血液・腫瘍科 46 349-353 2003年